利培酮微球(LAIR)在精神分裂症治疗中应用的价值分析
摘要:目的:分析与探讨利培酮微球在治疗精神分裂症中的应用价值。方法:选取48名在我院治疗一年以上的精神分裂患者,对其进行4周的利培酮微球口服与注射,此后进行8周的利培酮微球注射治疗。通过CGI-S(临床总体印象-严重度量表)、PANSS(阴阳症状量表)以及PSP(社会与人际能力量表)对患者治疗效果进行评定。结果:通过利培酮微球对患者进行8周的治疗后,治疗有效率达到80.5%,而且利培酮微球对患者体重影响比较小,患者体格、生命体征以及心电图等没有明显改变,治疗效果显著。结论:在精神分裂症治疗中,利培酮微球能够有效改善精神分裂者社会功能,值得临床应用与推广。
关键词:利培酮微球;精神分裂症;抗精神病药物;应用价值
〖WTHZ〗Abstract:Objective:〖WT〗to analyze and explore risperidone microsphere application value in the treatment of schizophrenia.〖WTHZ〗Methods:〖WT〗select 48 above one year of schizophrenia patients treated in our hospital, 4 weeks to oral risperidone microsphere injection and after eight weeks of risperidone microsphere injection treatment.Through the CGI-S (overall impression-clinical severity scale), PANSS symptom checklist (Yin and Yang) and PSP (social and interpersonal ability scale) to assess the therapeutic effect in patients with.〖WTHZ〗Results:〖WT〗by risperidone microsphere for patients after 8 weeks of treatment, treatment efficiency reached 80.5%, and risperidone microsphere effect on body weight in patients with small, physical, vital signs and electrocardiogram (ecg) in patients with no obvious change, treatment effect is remarkable.〖WTHZ〗Conclusion:〖WT〗in the treatment of schizophrenia, risperidone microsphere can effectively improve schizophrenic social function, worthy of clinical application and promotion.
〖WTHZ〗【key words】〖WT〗risperidone microsphere; schizophrenia; and antipsychotic drugs; application value
【中图分类号】R749.3【文献标识码】A【文章编号】1672-378...
== 试读已结束,如需继续阅读敬请充值会员 ==
|
本站文章均为原创投稿,仅供下载参考,付费用户可查看完整且有格式内容!
(费用标准:38元/2月,98元/2年,微信支付秒开通!) |
升级为会员即可查阅全文 。如需要查阅全文,请 免费注册 或 登录会员 |